Advertisement
Advertisement

FENC

FENC logo

Fennec Pharmaceuticals Inc. Common Stock

6.77
USD
Sponsored
-0.26
-3.70%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

6.78

+0.01
+0.07%

Fennec Pharmaceuticals Inc. Common Stock Profile

About

Fennec Pharmaceuticals Inc. is a clinical-stage biotechnology company. It is focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. The Company's products include Eniluracil and Sodium Thiosulfate (STS). Fennec Pharmaceuticals Inc., formerly known as Adherex Technologies Inc., is based in United States.

Info & Links

CEO

Jeffrey Hackman

Headquarters

PO BOX 13628,68 TW ALEXANDER DRIVE
RESEARCH TRIANGLE PARK, NC 27709, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

http://www.fennecpharma.com

Auditor

HASKELL & WHITE LLP

Share holders

27

Employees

35

Fennec Pharmaceuticals Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

235.18M

Enterprise Value

198.39M

Enterprise Value/EBITDA(ttm)

-32.45

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

4.94

Price to Book(mrq)

6.16

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

91.90%

Operating Margin(ttm)

-18.09%

Profit Margin(ttm)

-21.46%

Return on Equity(ttm)

-183.18%

Return on Invested Capital(ttm)

-57.38%

Return on Assets(ttm)

-15.31%

Income Statement

Revenue(ttm)

44.64M

Revenue Per Share(ttm)

1.29

Gross Profit(ttm)

40.88M

EBITDA(ttm)3

-6.11M

Net Income Available to Common(ttm)

-9.74M

Diluted EPS(ttm)

-0.34

Share Statistics

Beta (5Y Monthly)

0.93

52-Week Change

4.48%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

34.48M

Dividend Yield

0.00%

Float4

30.42M

% Held by Insiders

11.76%

% Held by Institutions

55.51%

Balance Sheet

Total Cash(mrq)

36.79M

Total Cash Per Share(mrq)

1.07

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.37%

Quick Ratio(mrq)

6.23%

Book Value Per Share(mrq)

1.04

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.44

Free Cash Flow(ytd)

-12.47M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement